Varex Imaging Stock (NASDAQ:VREX)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$11.48

52W Range

$10.19 - $21.50

50D Avg

$12.98

200D Avg

$16.42

Market Cap

$483.44M

Avg Vol (3M)

$576.75K

Beta

0.56

Div Yield

-

VREX Company Profile


Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

2,300

IPO Date

Jan 23, 2017

Website

VREX Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceSep 23Sep 22Oct 21
Medical Segment$673.30M--
Industrial Segment$220.10M--
Industrial-$184.70M$174.30M
Medical-$674.70M$643.80M

Fiscal year ends in Sep 23 | Currency in USD

VREX Financial Summary


Sep 23Sep 22Oct 21
Revenue$893.40M$859.40M$818.10M
Operating Income$77.10M$50.70M$33.40M
Net Income$48.20M$30.30M$17.40M
EBITDA$60.60M$84.30M$70.70M
Basic EPS$1.20$0.76$0.44
Diluted EPS$1.08$0.73$0.43

Fiscal year ends in Sep 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Aug 03, 24 | 2:46 PM
Q2 24May 02, 24 | 12:00 AM
Q1 24Feb 06, 24 | 11:25 PM

Peer Comparison


TickerCompany
FNAParagon 28, Inc.
APYXApyx Medical Corporation
IRMDIRadimed Corporation
BRKRBruker Corporation
OFIXOrthofix Medical Inc.
SGHTSight Sciences, Inc.
ITGRInteger Holdings Corporation
NPCENeuroPace, Inc.
NVRONevro Corp.
KIDSOrthoPediatrics Corp.
SIBNSI-BONE, Inc.
GKOSGlaukos Corporation
AORTArtivion, Inc.
CVRXCVRx, Inc.
CNMDCONMED Corporation